Furiex

Morrisville, United States Founded: 2009 • Age: 17 yrs Acquired By Actavis
Drug development for gastroenterology disorders is conducted.
Request Access

About Furiex

Furiex is a company based in Morrisville (United States) founded in 2009 was acquired by Actavis in April 2014.. Furiex offers products and services including RINVOQ and TrenibotulinumtoxinE. Furiex operates in a competitive market with competitors including Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others.

  • Headquarter Morrisville, United States
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Furiex Pharmaceuticals, Inc
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
  • Investors
  • Employee Count
    Employee Count
  • Acquired by
    Actavis

    (Apr 28, 2014)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Furiex

Furiex offers a comprehensive portfolio of products and services, including RINVOQ and TrenibotulinumtoxinE. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Treats adults with giant cell arteritis and other inflammatory conditions.

Addresses glabellar lines with rapid onset action.

Funding Insights of Furiex

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Furiex

Furiex has secured backing from 1 investor. Prominent investors backing the company include Actavis. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Investor Description Founded Year Domain Location
Manufacturer of generic products
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Furiex

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Furiex

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Furiex Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Furiex

Furiex operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Ironwood Pharma, Ardelyx, RedHill Biopharma, Cosmo Pharmaceuticals and Alcresta, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Therapeutics for gastrointestinal disorders, including linaclotide, are developed.
domain founded_year HQ Location
Therapeutics for gastrointestinal, cardio-renal, and metabolic diseases are developed.
domain founded_year HQ Location
Developer of therapeutics for the treatment of gastrointestinal and infectious diseases
domain founded_year HQ Location
Therapeutics for gastrointestinal diseases are developed and provided.
domain founded_year HQ Location
Enzyme-based products for gastrointestinal disorders are developed using immobilization technology.
domain founded_year HQ Location
Synbiotics are developed for simulating the gut microbiome.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Furiex

Frequently Asked Questions about Furiex

When was Furiex founded?

Furiex was founded in 2009.

Where is Furiex located?

Furiex is headquartered in Morrisville, United States.

What does Furiex do?

Furiex Pharmaceuticals was established in 2009 in Morrisville, United States, within the pharmaceutical sector. Focus was placed on developing eluxadoline, a mu opioid receptor agonist and delta opioid receptor antagonist, targeted at diarrhea-predominant irritable bowel syndrome. Two Phase III clinical trials were completed in 2014, meeting primary endpoints for stool consistency and abdominal pain improvements as agreed with FDA and EMA. Acquisition by Actavis occurred in 2014.

Who are the top competitors of Furiex?

Furiex's top competitors include Ironwood Pharma, Ardelyx and RedHill Biopharma.

What products or services does Furiex offer?

Furiex offers RINVOQ and TrenibotulinumtoxinE.

Who are Furiex's investors?

Furiex has 1 investor. Key investors include Actavis.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available